# Anaptysbio, Inc: Form SC 13D/A, filed Aug 16, 2024

- Company: [Anaptysbio, Inc](/companies/anab.md) (CIK 1370053)
- Form: SC 13D/A
- Filed: 2024-08-16
- Accepted by EDGAR: Aug 16, 2024, 16:07 ET
- Period: not reported
- Accession: 0000935836-24-000533
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1370053/000093583624000533/anab13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1370053/000093583624000533/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1370053/000093583624000533/anab13da.htm

Filed Aug 16, 2024.
Source: SEC EDGAR, the filing index for accession 0000935836-24-000533. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.